|
| 36976280 | Extended Follow-up of Microbiome Therapeutic SER-109 for Recurrent Clostridioides difficile Infection-Reply. | | 2023 |
| 36780159 | Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial. | JAMA Netw Open | 2023 |
| 36716031 | Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical Trial. | | 2023 |
| 37540090 | Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor Stool. | | 2023 |
| 37539715 | Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based Therapeutic. | Clin Infect Dis | 2023 |
| 35045228 | SER-109, an Oral Microbiome Therapy for Recurrent <i>Clostridioides difficile</i> Infection. | N Engl J Med | 2022 |
| 36158136 | Manufacturing Process of SER-109, a Purified Investigational Microbiome Therapeutic, Reduces Risk of Coronavirus Transmission From Donor Stool. | Open Forum Infectious Diseases | 2022 |
| 36260754 | Extended Follow-up of Microbiome Therapeutic SER-109 Through 24 Weeks for Recurrent Clostridioides difficile Infection in a Randomized Clinical Trial. | JAMA - Journal of the American Medical Association | 2022 |
| 32763240 | A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis. | Gastroenterology | 2021 |
| 32255488 | SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. | Clin Infect Dis | 2021 |
| 32405509 | The Efficacy and Safety of Fecal Microbiota Transplant for Recurrent Infection: Current Understanding and Gap Analysis. | Open Forum Infectious Diseases | 2020 |
| 26330025 | Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy. | Clinical Pharmacokinetics | 2016 |
| 26973850 | Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative. | Open Forum Infectious Diseases | 2016 |
| 26908752 | A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection. | J Infect Dis | 2016 |
| 26098993 | Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort. | Journal of Viral Hepatitis | 2015 |
| 25883387 | Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 Study. | Journal of Infectious Diseases | 2015 |
| 25839406 | Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine. | Journal of Hepatology | 2015 |
| 25837807 | Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study. | PLoS ONE | 2015 |
| 25706092 | Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial. | JAMA | 2015 |
| 25580520 | Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study. | Journal of Viral Hepatitis | 2015 |
| 26121304 | Underascertainment of acute hepatitis C virus infections in the U.S. surveillance system: a case series and chart review. | Annals of Internal Medicine | 2015 |
| 23908124 | The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. | Hepatology | 2014 |
| 25256151 | Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study. | Journal of Clinical Virology | 2014 |
| 23203695 | Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study. | International Journal of Epidemiology | 2013 |
| 23111904 | A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users. | Hepatology | 2013 |
| 23596276 | Impact of new therapeutics for hepatitis C virus infection in incarcerated populations. | Topics in antiviral medicine | 2013 |
| 22213804 | Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence. | J Exp Med | 2012 |
| 22491341 | Editorial commentary: Hepatitis C virus and the infectious disease physician: a perfect match. | Clinical Infectious Diseases | 2012 |
| 23154253 | Syphilis negatively influences the response to hepatitis C virus treatment in an HIV-infected patient. | Topics in antiviral medicine | 2012 |
| 23083830 | Care of the patient with hepatitis C virus infection. Preface. | Infectious Disease Clinics of North America | 2012 |
| 22239520 | The association of HIV viral load with indirect markers of liver injury. | Journal of Viral Hepatitis | 2012 |
| 21276415 | Hepatic steatosis in HIV/HCV-coinfected patients: time to reevaluate! | Gastroenterology | 2011 |
| 21177046 | Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy. | | 2011 |
| 21189425 | A "one-two punch" leading to hepatitis C seroconversion. | Clinical Infectious Diseases | 2011 |
| 21051598 | The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. | Science | 2010 |
| 19673649 | Rate of sustained virologic response in relation to baseline hepatitis C virus (HCV) RNA level and rapid virologic clearance in persons with acute HCV infection. | J Infect Dis | 2009 |
| 19409289 | Acute hepatitis C infection in correctional settings. | Gastroenterology | 2009 |
| 19496835 | The individual and combined influence of HIV and hepatitis C virus on dyslipidaemia in a high-risk Hispanic population. | HIV Medicine | 2009 |
| 19725787 | Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria. | Clin Infect Dis | 2009 |
| 18090386 | Antiretroviral drugs and liver injury. | AIDS | 2008 |
| 18681193 | A golden opportunity: the treatment of hepatitis C in HIV-infected inmates. | Journal of Addictive Diseases | 2008 |
| 18160439 | High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome. | J Virol | 2008 |
| 18972443 | Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection. | Hepatology | 2008 |
| 18284178 | The epidemiology, natural history and prevention of hepatitis B: implications of HIV coinfection. | Antiviral Therapy | 2007 |
| 17704692 | Hepatitis C in the HIV-infected patient. | Journal of acquired immune deficiency syndromes (1999) | 2007 |
| 17205454 | The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients. | Clinical Infectious Diseases | 2007 |
| 17968840 | Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferon. | Clinical Infectious Diseases | 2007 |
| 17342661 | Antiretroviral therapy for patients with HIV-hepatitis B virus coinfection. | Clinical Infectious Diseases | 2007 |
| 16750959 | Back to basics. | American Journal of Medicine | 2006 |
| 16705568 | Acute hepatitis C virus infection in incarcerated injection drug users. | Clin Infect Dis | 2006 |